BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21615919)

  • 21. Comparative cytogenetic characterization of primary canine melanocytic lesions using array CGH and fluorescence in situ hybridization.
    Poorman K; Borst L; Moroff S; Roy S; Labelle P; Motsinger-Reif A; Breen M
    Chromosome Res; 2015 Jun; 23(2):171-86. PubMed ID: 25511566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel canine kidney cell line model for the evaluation of neoplastic development: karyotype evolution associated with spontaneous immortalization and tumorigenicity.
    Omeir R; Thomas R; Teferedegne B; Williams C; Foseh G; Macauley J; Brinster L; Beren J; Peden K; Breen M; Lewis AM
    Chromosome Res; 2015 Dec; 23(4):663-80. PubMed ID: 25957863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.
    Aricò A; Ferraresso S; Bresolin S; Marconato L; Comazzi S; Te Kronnie G; Aresu L
    PLoS One; 2014; 9(11):e111817. PubMed ID: 25372838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas.
    Thomas R; Seiser EL; Motsinger-Reif A; Borst L; Valli VE; Kelley K; Suter SE; Argyle D; Burgess K; Bell J; Lindblad-Toh K; Modiano JF; Breen M
    Leuk Lymphoma; 2011 Jul; 52(7):1321-35. PubMed ID: 21375435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical prognostic factors in canine histiocytic sarcoma.
    Dervisis NG; Kiupel M; Qin Q; Cesario L
    Vet Comp Oncol; 2017 Dec; 15(4):1171-1180. PubMed ID: 27334037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN.
    Borge KS; Nord S; Van Loo P; Lingjærde OC; Gunnes G; Alnæs GI; Solvang HK; Lüders T; Kristensen VN; Børresen-Dale AL; Lingaas F
    PLoS One; 2015; 10(5):e0126371. PubMed ID: 25955013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Factors Associated with Development of Histiocytic Sarcoma in Bernese Mountain Dogs.
    Ruple A; Morley PS
    J Vet Intern Med; 2016 Jul; 30(4):1197-203. PubMed ID: 27160025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Histiocytic sarcoma in the Swiss population of Bernese mountain dogs: a retrospective study of its genetic predisposition].
    Voegeli E; Welle M; Hauser B; Dolf G; Flückiger M
    Schweiz Arch Tierheilkd; 2006 Jun; 148(6):281-8. PubMed ID: 16826705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copy number abnormalities in sporadic canine colorectal cancers.
    Tang J; Le S; Sun L; Yan X; Zhang M; Macleod J; Leroy B; Northrup N; Ellis A; Yeatman TJ; Liang Y; Zwick ME; Zhao S
    Genome Res; 2010 Mar; 20(3):341-50. PubMed ID: 20086242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The two main forms of histiocytic sarcoma in the predisposed Flatcoated retriever dog display variation in gene expression.
    Boerkamp KM; van Steenbeek FG; Penning LC; Groot Koerkamp MJ; van Leenen D; Vos-Loohuis M; Grinwis GC; Rutteman GR
    PLoS One; 2014; 9(6):e98258. PubMed ID: 24886914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of the two-base insertion mutation in the TP53 gene in canine histiocytic sarcoma.
    Asada H; Tomiyasu H; Okada K; Chambers JK; Goto-Koshino Y; Uchida K; Kagawa Y; Ohno K; Tsujimoto H
    Res Vet Sci; 2019 Jun; 124():57-60. PubMed ID: 30852355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A genome assembly-integrated dog 1 Mb BAC microarray: a cytogenetic resource for canine cancer studies and comparative genomic analysis.
    Thomas R; Duke SE; Karlsson EK; Evans A; Ellis P; Lindblad-Toh K; Langford CF; Breen M
    Cytogenet Genome Res; 2008; 122(2):110-21. PubMed ID: 19096206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a Hypomorphic
    Meek K; Yang YT; Takada M; Parys M; Richter M; Engleberg AI; Thaiwong T; Griffin RL; Schall PZ; Kramer AJ; Yuzbasiyan-Gurkan V
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma.
    Prouteau A; Denis JA; De Fornel P; Cadieu E; Derrien T; Kergal C; Botherel N; Ulvé R; Rault M; Bouzidi A; François R; Dorso L; Lespagnol A; Devauchelle P; Abadie J; André C; Hédan B
    Sci Rep; 2021 Jan; 11(1):877. PubMed ID: 33441840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histiocytic sarcoma in 14 miniature schnauzers - a new breed predisposition?
    Lenz JA; Furrow E; Craig LE; Cannon CM
    J Small Anim Pract; 2017 Aug; 58(8):461-467. PubMed ID: 28543363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine hemophagocytic histiocytic sarcoma: a proliferative disorder of CD11d+ macrophages.
    Moore PF; Affolter VK; Vernau W
    Vet Pathol; 2006 Sep; 43(5):632-45. PubMed ID: 16966440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The intratumor heterogeneity of TP53 gene mutations in canine histiocytic sarcoma.
    Asada H; Ichii O; Tomiyasu H; Uchida K; Chambers JK; Goto-Koshino Y; Ohno K; Kon Y; Tsujimoto H
    J Vet Med Sci; 2019 Mar; 81(3):353-356. PubMed ID: 30662044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canine urothelial carcinoma: genomically aberrant and comparatively relevant.
    Shapiro SG; Raghunath S; Williams C; Motsinger-Reif AA; Cullen JM; Liu T; Albertson D; Ruvolo M; Bergstrom Lucas A; Jin J; Knapp DW; Schiffman JD; Breen M
    Chromosome Res; 2015 Jun; 23(2):311-31. PubMed ID: 25783786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the Clinical Characteristics of Histiocytic Sarcoma in Bernese Mountain Dogs and Flat-Coated Retrievers.
    Erich SA; Dobson JM; Teske E
    Vet Sci; 2022 Sep; 9(9):. PubMed ID: 36136714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activating Mutations in
    Takada M; Smyth LA; Thaiwong T; Richter M; Corner SM; Schall PZ; Kiupel M; Yuzbasiyan-Gurkan V
    Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31277422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.